ADHERENCE TO NATIONAL CHOLESTEROL EDUCATION-PROGRAM TREATMENT GOALS IN POSTMENOPAUSAL WOMEN WITH HEART-DISEASE - THE HEART AND ESTROGEN PROGESTIN REPLACEMENT STUDY (HERS)/
Hg. Schrott et al., ADHERENCE TO NATIONAL CHOLESTEROL EDUCATION-PROGRAM TREATMENT GOALS IN POSTMENOPAUSAL WOMEN WITH HEART-DISEASE - THE HEART AND ESTROGEN PROGESTIN REPLACEMENT STUDY (HERS)/, JAMA, the journal of the American Medical Association, 277(16), 1997, pp. 1281-1286
Objectives.-To determine the proportion of volunteer women with establ
ished heart disease who have low-density lipoprotein cholesterol (LDL-
C) levels at or below the National Cholesterol Education Program Adult
Treatment Panel goals and to determine what factors are associated wi
th levels above goal or not receiving lipid-lowering medication when i
ndicated. Design.-Cross-sectional measurement of lipids and lipoprotei
ns, blood pressure, height, weight, and other demographic and cardiova
scular risk factors in 2763 postmenopausal women with heart disease. S
etting.-At 18 centers throughout the United States, participants were
recruited by means of lists of women with coronary heart disease from
coronary units and catheterization laboratories, direct mail to age-el
igible women, and advertisements. Patients.-Mean age of the cohort was
66.7 years (range, 44-79 years) and the distribution by race/ethnicit
y was 88.7% white, 7.9% African American, 2.0% Hispanic/Latina, 0.8% A
sian/Pacific Islander, and 0.7% other. Intervention.-We report cross-s
ectional analysis of the cohort at baseline. Outcome Measures.-We meas
ured the frequency of achieving 1988 and 1993 Adult Treatment Panel tr
eatment goals, and of being on a regimen of lipid-lowering medication.
Results.-Although 47% of participants were taking a lipid-lowering me
dication, 63% did not meet the 1988 treatment goal of LDL-C level less
than 3.4 mmol/L (130 mg/dL) and 91% did not meet the 1993 goal of LDL
-C level less than 2.6 mmol/L (100 mg/dL). Factors independently assoc
iated with achieving the earlier goal were use of lipid-lowering medic
ation, marital status, education, body mass index, exercise, hypertens
ion, diabetes, gallbladder disease, and first diagnosis of coronary he
art disease after 1990. Failure to use lipid-lowering medication was a
ssociated with age, being African American, marital status, body mass
index, lack of exercise, alcohol consumption, current smoking, and fir
st diagnosis of coronary heart disease before 1985. Conclusion.-The ma
jority of women enrolled in the trial had LDL-C levels that significan
tly exceeded the treatment goals set by the 1988 and 1993 Adult Treatm
ent Panel guidelines. Better implementation of these guidelines among
women with coronary disease would be highly desirable.